Synergistic effects of angiotensinogen −217 G→A and T704C (M235T) variants on the risk of severe preeclampsia

Background: The rate-limiting step of the renin–angiotensin system is the enzymatic cleavage of angiotensinogen (AGT) by renin. The aims of the present study were to investigate the association between AGT T704C (M235T) and −217 G→A polymorphisms with the risk of preeclampsia and synergistic effects...

Full description

Bibliographic Details
Main Authors: Farhad Shahvaisizadeh, Abolfazl Movafagh, Mir Davood Omrani, Asad Vaisi-Raygani, Ziba Rahimi, Zohreh Rahimi
Format: Article
Language:English
Published: SAGE Publications 2014-06-01
Series:Journal of the Renin-Angiotensin-Aldosterone System
Online Access:https://doi.org/10.1177/1470320312467555
_version_ 1797288521725116416
author Farhad Shahvaisizadeh
Abolfazl Movafagh
Mir Davood Omrani
Asad Vaisi-Raygani
Ziba Rahimi
Zohreh Rahimi
author_facet Farhad Shahvaisizadeh
Abolfazl Movafagh
Mir Davood Omrani
Asad Vaisi-Raygani
Ziba Rahimi
Zohreh Rahimi
author_sort Farhad Shahvaisizadeh
collection DOAJ
description Background: The rate-limiting step of the renin–angiotensin system is the enzymatic cleavage of angiotensinogen (AGT) by renin. The aims of the present study were to investigate the association between AGT T704C (M235T) and −217 G→A polymorphisms with the risk of preeclampsia and synergistic effects of both polymorphisms on the susceptibility to preeclampsia. Methods: We studied AGT variants in 170 women with preeclampsia, including 84 women with mild and 86 women with severe forms of preeclampsia, and 100 age and parity matched controls. Results: There was a trend towards increased risk of severe preeclampsia in the presence of −217 AA (odds ratio (OR)=1.5, 95% confidence interval (CI)= 0.38–5.84, p =0.57) and TC+CC genotypes (OR=1.32, 95% CI= 0.67–2.58, p =0.42). However, the interaction of both alleles of −217A and 704C highly increased the risk of severe preeclampsia, by 2.23-fold, although this did not reach statistical significance. The frequency of the CC genotype of the T704C polymorphism in early-onset preeclampsia tended to be higher (35%) compared with that in patients with late-onset preeclampsia (21.7%). Conclusions: The present study demonstrates that both variants of AGT −217 G→A and T704C might work in synergism to influence the risk of severe preeclampsia, which needs to be confirmed in studies with larger sample size.
first_indexed 2024-03-07T18:50:42Z
format Article
id doaj.art-bfe4bbf6121d4eb09cd3b962f62edeee
institution Directory Open Access Journal
issn 1470-3203
1752-8976
language English
last_indexed 2024-03-07T18:50:42Z
publishDate 2014-06-01
publisher SAGE Publications
record_format Article
series Journal of the Renin-Angiotensin-Aldosterone System
spelling doaj.art-bfe4bbf6121d4eb09cd3b962f62edeee2024-03-02T01:47:58ZengSAGE PublicationsJournal of the Renin-Angiotensin-Aldosterone System1470-32031752-89762014-06-011510.1177/1470320312467555Synergistic effects of angiotensinogen −217 G→A and T704C (M235T) variants on the risk of severe preeclampsiaFarhad Shahvaisizadeh0Abolfazl Movafagh1Mir Davood Omrani2Asad Vaisi-Raygani3Ziba Rahimi4Zohreh Rahimi5Department of Medical Genetics, Medical School, Shahid Beheshti University of Medical Sciences, IranDepartment of Medical Genetics, Medical School, Shahid Beheshti University of Medical Sciences, IranDepartment of Medical Genetics, Medical School, Shahid Beheshti University of Medical Sciences, IranDepartment of Biochemistry, Medical School, Kermanshah University of Medical Sciences, IranMedical Biology Research Center, Kermanshah University of Medical Sciences, IranMedical Biology Research Center, Kermanshah University of Medical Sciences, IranBackground: The rate-limiting step of the renin–angiotensin system is the enzymatic cleavage of angiotensinogen (AGT) by renin. The aims of the present study were to investigate the association between AGT T704C (M235T) and −217 G→A polymorphisms with the risk of preeclampsia and synergistic effects of both polymorphisms on the susceptibility to preeclampsia. Methods: We studied AGT variants in 170 women with preeclampsia, including 84 women with mild and 86 women with severe forms of preeclampsia, and 100 age and parity matched controls. Results: There was a trend towards increased risk of severe preeclampsia in the presence of −217 AA (odds ratio (OR)=1.5, 95% confidence interval (CI)= 0.38–5.84, p =0.57) and TC+CC genotypes (OR=1.32, 95% CI= 0.67–2.58, p =0.42). However, the interaction of both alleles of −217A and 704C highly increased the risk of severe preeclampsia, by 2.23-fold, although this did not reach statistical significance. The frequency of the CC genotype of the T704C polymorphism in early-onset preeclampsia tended to be higher (35%) compared with that in patients with late-onset preeclampsia (21.7%). Conclusions: The present study demonstrates that both variants of AGT −217 G→A and T704C might work in synergism to influence the risk of severe preeclampsia, which needs to be confirmed in studies with larger sample size.https://doi.org/10.1177/1470320312467555
spellingShingle Farhad Shahvaisizadeh
Abolfazl Movafagh
Mir Davood Omrani
Asad Vaisi-Raygani
Ziba Rahimi
Zohreh Rahimi
Synergistic effects of angiotensinogen −217 G→A and T704C (M235T) variants on the risk of severe preeclampsia
Journal of the Renin-Angiotensin-Aldosterone System
title Synergistic effects of angiotensinogen −217 G→A and T704C (M235T) variants on the risk of severe preeclampsia
title_full Synergistic effects of angiotensinogen −217 G→A and T704C (M235T) variants on the risk of severe preeclampsia
title_fullStr Synergistic effects of angiotensinogen −217 G→A and T704C (M235T) variants on the risk of severe preeclampsia
title_full_unstemmed Synergistic effects of angiotensinogen −217 G→A and T704C (M235T) variants on the risk of severe preeclampsia
title_short Synergistic effects of angiotensinogen −217 G→A and T704C (M235T) variants on the risk of severe preeclampsia
title_sort synergistic effects of angiotensinogen 217 g a and t704c m235t variants on the risk of severe preeclampsia
url https://doi.org/10.1177/1470320312467555
work_keys_str_mv AT farhadshahvaisizadeh synergisticeffectsofangiotensinogen217gaandt704cm235tvariantsontheriskofseverepreeclampsia
AT abolfazlmovafagh synergisticeffectsofangiotensinogen217gaandt704cm235tvariantsontheriskofseverepreeclampsia
AT mirdavoodomrani synergisticeffectsofangiotensinogen217gaandt704cm235tvariantsontheriskofseverepreeclampsia
AT asadvaisiraygani synergisticeffectsofangiotensinogen217gaandt704cm235tvariantsontheriskofseverepreeclampsia
AT zibarahimi synergisticeffectsofangiotensinogen217gaandt704cm235tvariantsontheriskofseverepreeclampsia
AT zohrehrahimi synergisticeffectsofangiotensinogen217gaandt704cm235tvariantsontheriskofseverepreeclampsia